Qualtech: Medical Device Consulting

Product Registration, Clinical Trials, Local Representative, and Regulatory Services

Qualtech Consulting Corporation, founded in 2000 by Dr. Yin-Pen Chang, is a regulatory consulting service and clinical trial (CRO) company for medical devices. Operating with a cross-disciplinary team of professionals, integrity, diversity, continuous learning, and teamwork, Qualtech provides clients with effective one-stop solutions.
We have helped over 1,000 clients to gain market access in their desired locations and passed more than 5,000 medical device licenses with precision.

Qualtech News

2026-04-02

Vietnam: Regulatory Update on Goods Labeling under Decree No. 37/2026/ND-CP – February/March 2026

Decree No. 37/2026/ND-CP introduces updated labeling requirements in Vietnam, replacing previous regulations. It strengthens and supplements the rules on mandatory label information, while also introducing additional provisions on electronic labeling and specific requirements for medical devices. Transitional provisions are included to support the continued use of previously compliant labels for a limited period.

2026-04-02

SINGAPORE: HSA responds to consultation on proposed AI-SaMD licensing and registration exemption for selected public healthcare entities – February/March 2026

Health Sciences Authority (HSA) has responded to feedback from its public consultation on a proposed regulatory sandbox that exempts selected low‑risk artificial intelligence software as a medical device (AI‑SaMD) from manufacturer licensing and product registration requirements under controlled conditions. The sandbox aims to balance regulatory oversight and innovation by allowing public healthcare institutions to develop and deploy AI tools for non‑critical medical conditions while collecting real‑world insights to inform future regulatory frameworks.

2026-04-01

Philippines: An Overview of the Proposed PFDA Guidelines for Medical Device Surveillance and Traceability – February/March 2026

The proposed PFDA guidelines establish requirements for maintaining importation and distribution records and for reporting product complaints, adverse events, and field safety corrective actions for medical devices to ensure traceability and facilitate appropriate regulatory action. This article outlines the specific responsibilities, strict reporting timelines, and record-keeping mandates designed to protect public health throughout the device lifecycle.

2026-04-01

MALAYSIA: Implementation of Medical Device Authority (PBPP) Circular No.1 of 2026 – February/March 2026

The Malaysia Medical Device Authority (MDA) has implemented Circular Letter No. 1 Year 2026 that enforces a compulsory licensing for all medical device tenderers to possess a valid Establishment License. Compliance with Act 737 and related regulations is mandatory, with penalties for violations.

Qualtech Your best choice

Medical Device Registration

Having 20 years of regulatory registration experience, we offer product registration services in 10 Asian countries. Moreover, we set up the sales center in Japan, United State and Europe to provide direct customer service.

Clinical Trials

We provide a full range of services including clinical trials, clinical evaluation reports and post-marketing clinical follow-up. We are the first company to implement and pass the GCP by Taiwan FDA. We have also passed many GCP in China.

Authorized Representative

We can act as a local product license manager at the manufacturing facility. Help you with such activities as regulations and post-marketing tracking, and provide immediate regulatory updates.

Qualtech Solution

E-mail

Obtain Market Access via CER